Secondary Malignant Neoplasm — Trials

Secondary Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

14,671 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,275
Recruiting: 2,321
Ph III recruiting: 272
Growth YoY: +12.3%
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,961)

clinicaltrialsPublishedShowing 551–600 of 2,851 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06944483	Same-day Radioembolization for Large HCC(ISTAR-01)	recruiting	—	138	Seoul National University HospitalOTHER	1	Aug 18, 2026	clinicaltrials
NCT06966024	Study of DCC-2812 in Participants With Advanced Genitourinary Cancers	recruiting	Phase 1	60	Deciphera Pharmaceuticals, LLCINDUSTRY	1	Aug 18, 2026	clinicaltrials